All In Biotech

Drug Trial Radar · NCT07061938

Study to Assess Safety, Efficacy and Persistence of ACE1831, in Subjects With IgG4-Related Disease

Phase 1b/2a Prospective, Open Label, Multicenter, Two-Arm Study to Assess Safety, Efficacy and Persistence of ACE1831, in Subjects With Immunoglobulin G4-Related Disease

Last checked: Nov 19, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

34

Planned (sponsor's estimate)

Start

Jan 1, 2026

Primary completion

Sep 20, 2029

Study completion Sep 20, 2029

Sponsor

Lead sponsor
Acepodia Biotech, Inc.Industry
Sponsor type
Industry
First posted
Jul 14, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

ACE1831 is an off-the-shelf, allogeneic gamma delta T (gdT) cell therapy derived from healthy donors, that is under investigation for the treatment in subjects with Immunoglobulin G4 Related Disease (IgG4-RD)

Conditions

  • IgG4 Related Disease

Interventions

  • ACE1831Drug

    ACE1831 is allogeneic gamma delta T (gdT) cell therapy. Subjects will receive ACE1831 dose based on the assigned dose escalation cohort.

  • Lymphodepleting chemotherapyDrug

    Subjects assigned to receive lymphodepleting preconditioning (LDC) will receive chemotherapy (fludarabine and cyclophosphamide) ahead of ACE1831 administration.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety and Tolerability of ACE1831 as Assessed by Adverse Events, Clinical Laboratory Tests, Physical Examinations, ECGs, and Vital SignsTime frame: up to 72 weeks post first-ACE1831 dose

Locations

11 sites in 3 countries. Site status is shown where the registry gives one.

  • Emory University

    Atlanta, Georgia

  • Massachusetts General Hospital

    Boston, Massachusetts

  • Beijing Friendship Hospital

    Beijing, China

  • Peking Union Medical College Hospital

    Beijing, China

  • Sichuan University - West China Hospital

    Chengdu, China

  • The Second Affiliated Hospital of Zhejiang University School of Medicine

    Hangzhou, China

  • The First Affiliated Hospital-University of Science and Technology of China

    Hefei, China

  • Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine

    Shanghai, China

  • Bethune Hospital Shanxi Academy of Medical Sciences

    Taiyuan, China

  • Huazhong University of Science and Technology-Tongji Hospital (TJH)

    Wuhan, China

  • Kanazawa Medical University Hospital

    Kahoku-gun, JP, Japan

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.